Alphabetically   > V   > Vernalis plc  

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
 

Vernalis plc

transparent spacer
transparent spacer
transparent spacer

Company Information

Address:

Oakdene Court 613 Reading Road
Winnersh
Wokingham
Berkshire
RG41 5UA

Tel:

0118 989 9300

Fax:

0118 989 9300

E-Mail:

Secretary:

Alison Hood

Registrar:

Capita Registrars Huddersfield Ltd

Company Overview

Vernalis is a UK-based biotechnology company with a marketed product, Frovatriptan, to treat migraine and a development pipeline focused on CNS disease and oncology. The company has five products in clinical development and collaborations with leading, global pharmaceutical companies including Novartis, Biogen Idec and Serono. Vernalis is establishing a US commercial operation to co-promote frovatriptan alongside its North American licensing partner, Endo Pharmaceuticals, propelling the company towards its goal of becoming a sustainable, self-funding, R&D-driven biotechnology company.

Company Strategy

Drug discovery and development is a highly complex business. They take a proactive, risk-based approach to the process, founded on diversification and constant practical and commercial evaluation of our candidates.

As well as maintaining a tight, commercially-driven pipeline, Vernalis aims to leverage the key strengths of our organisation to maximum advantage. These strengths include:

- Dynamic and experienced leadership
- Strong cash position
- Broad and maturing pipeline
- Highly productive quality research
- Partner validation

Annual Reports

Description Report Date Published
Annual Report 2009 in PDF * 31/12/2009 9/04/2010
Annual Report 2008 in PDF 31/12/2008 29/04/2009
Annual Report 2007 in PDF 31/12/2007 12/05/2008

Interim Reports

Description Report Date Published
Interim Results 2010 in PDF * 30/06/2010 29/07/2010
Interim Results 2009 in PDF 30/06/2009 6/08/2009
Interim Results 2008 in PDF 30/06/2008 28/08/2008
Interim Results 2007 in PDF 30/06/2007 13/09/2007
 
Other Links
Description
bullet point Home
bullet point Investor Relations
bullet point Results Index
bullet point Presentations
bullet point Contacts
A B C D E F G H I J K L M
N O P Q R S T U V W X Y Z